Mostrar el registro sencillo del ítem
dc.contributor.author | Pedrosa Naudín, M. Aránzazu | |
dc.contributor.author | Gutiérrez Abejón, Eduardo | |
dc.contributor.author | Herrera Gómez, Francisco Magno | |
dc.contributor.author | Fernández Lázaro, Diego | |
dc.contributor.author | Álvarez González, Francisco Javier | |
dc.date.accessioned | 2023-07-14T11:33:45Z | |
dc.date.available | 2023-07-14T11:33:45Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Pharmaceutics, 2022, Vol. 14, Nº. 12, 2696 | es |
dc.identifier.issn | 1999-4923 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/60298 | |
dc.description | Producción Científica | es |
dc.description.abstract | Antidepressants are a commonly prescribed psychotropic medication, and their use has increased in recent years. Medication non-adherence in patients with mental disorders is associated with worse health outcomes. A population-based registry study to assess antidepressant non-adherence during 2021 has been carried out. An indirect method based on the medication possession ratio (MPR) has been utilized. Patients with a MPR under 80% were classified as non-adherent. A multivariate logistic regression to identify non-adherence predictors has been used, considering sociodemographic (age, sex, institutionalization and urbanicity) and health related variables (diagnostics, antidepressant class, multiple prescribers, and polypharmacy). In 2021, 10.6% of the Castile and Leon population used antidepressants. These patients were institutionalized (7.29%), living in urban areas (63.44%), polymedicated with multiple prescribers (57.07%), and using serotonin selective reuptake inhibitors (SSRIs) (54.77%), other antidepressants (46.82%) or tricyclic antidepressants (TCAs) (13.76%). Antidepressants were prescribed mainly for depression (36.73%) and anxiety (29.24%). Non-adherence to antidepressants was more frequent in men (20.56%) than in woman (19.59%) and decreased with increasing age (32% up to 17 years old vs. 13.76% over 80 years old). TCAs were associated with the highest prevalence of non-adherence (23.99%), followed by SSRIs (20.19%) and other antidepressants (18.5%). Predictors of non-adherence in patients on antidepressants were: living in urban areas, using TCAs, and pain occurrence. Non-adherence to antidepressants decreases with aging. Being female, institutionalization, being polymedicated and having depression/anxiety alongside another psychiatric diagnosis are protective factors against non-adherence. The MPR is a robust indicator for the clinician to identify non-adherent patients for monitoring, and adopt any necessary corrective actions. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Antidepressants | es |
dc.subject | Antidepresivos | es |
dc.subject | Drug utilization | es |
dc.subject | Medicamentos - Uso | es |
dc.subject | Psychiatry | es |
dc.subject | Pharmacy | es |
dc.subject | Psychopharmacology | es |
dc.subject | Depression | es |
dc.subject | Depresión mental | es |
dc.subject | Anxiety | es |
dc.subject | Ansiedad | es |
dc.subject | Psychopathology | es |
dc.subject | Psychotropic drugs | es |
dc.subject | Drogas psicotrópicas | es |
dc.title | Non-adherence to antidepressant treatment and related factors in a region of Spain: A population-based registry study | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2022 The Authors | es |
dc.identifier.doi | 10.3390/pharmaceutics14122696 | es |
dc.relation.publisherversion | https://www.mdpi.com/1999-4923/14/12/2696 | es |
dc.identifier.publicationfirstpage | 2696 | es |
dc.identifier.publicationissue | 12 | es |
dc.identifier.publicationtitle | Pharmaceutics | es |
dc.identifier.publicationvolume | 14 | es |
dc.peerreviewed | SI | es |
dc.description.project | Instituto de Salud Carlos III y Fondo Europeo de Desarrollo Regional (FEDER) - (grant RD16/0017/0006) | es |
dc.identifier.essn | 1999-4923 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 3209 Farmacología | es |
dc.subject.unesco | 3211 Psiquiatría | es |
dc.subject.unesco | 3209.09 Psicofarmacología | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Atribución 4.0 Internacional